Burkett Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$270K Buy
233
+36
+18% +$42.5K 0.08% 51
2026
Q2
$237K Sell
197
-20
-9% -$20.4K 0.07% 47
2026
Q1
$200K Sell
217
-15
-6% -$15.2K 0.07% 49
2025
Q4
$250K Sell
232
-15
-6% -$14.3K 0.09% 45
2025
Q3
$188K Sell
247
-109
-31% -$81.1K 0.06% 54
2025
Q2
$278K Sell
356
-2
-0.6% -$1.55K 0.1% 44
2025
Q1
$296K Buy
358
+1
+0.3% +$832 0.12% 40
2024
Q4
$276K Sell
357
-11
-3% -$9.11K 0.11% 42
2024
Q3
$326K Buy
368
+1
+0.3% +$899 0.13% 39
2024
Q2
$333K Sell
367
-39
-10% -$31.2K 0.17% 36
2024
Q1
$316K Buy
406
+16
+4% +$11.4K 0.16% 37
2023
Q4
$227K Buy
+390
New +$228K 0.13% 40

Other funds holding LLY

Burkett Financial Services's LLY Position: Q3 2026 in Review

Burkett Financial Services increased its Eli Lilly (LLY) stake by 18% in Q3 2026, buying an estimated $42.5K and bringing the position to 233 shares worth $270K. The position accounts for 0.08% of the portfolio, ranked #51.

Burkett Financial Services first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $333K in Q2 2024. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Burkett Financial Services held 233 shares of Eli Lilly worth $270K as of Q3 2026.
  • Burkett Financial Services bought 36 Eli Lilly shares in Q3 2026, an estimated $42.5K.
  • Eli Lilly made up 0.08% of Burkett Financial Services's portfolio in Q3 2026, its #51 holding.
  • Burkett Financial Services first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Burkett Financial Services's Eli Lilly position peaked at $333K in Q2 2024.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.